MindMed, a Silicon Valley Startup, Tests Psychedelics to Treat Addiction

Psychedelic medicine is hot right now—or regulatory agencies seem to be warming up to the idea, at least. Over the last few years, the FDA has begun to approve (and even fast-track) clinical trials examining the impact of substances like ketamine, psilocybin, and MDMA on mental health issues like post-traumatic stress disorder and major depressive disorder. In addition to contributing to the growing ...

Continue Reading →

18-MC: Could it End the Opioid Epidemic?



An Interview with Dr. Stanley Glick, Co-Inventor of 18-MC, a Synthetic Derivative of Ibogaine, the Addiction Interruptor.

Stanley Glick, PhD, MD, shares his views on the past, present, and future of ibogaine and 18-MC and on the prejudice against addicts and psychedelic drugs which prevents vital medicines from being funded and researched.

awake.net is a collective wisdom blog about the inner journey with entheogens, and their ability to heal ...

Continue Reading →

Richard Hartnell – Psychedelic Science (MAPS) 2017 Interview



Please visit us for inspiration, ideas, information, and LOVE!
http://soulDocumentary.love

S.O.U.L. endeavors to further expand consciousness by sharing our experience from the MAPS sponsored Psychedelic Science 2017 conference, where the international scientific community came together at the Oakland Marriott City Center to explore new research into the benefits and risks of MDMA, LSD, psilocybin, ayahuasca, ketamine, ibogaine, medical cannabis, and more for such applications as: psychotherapy, neuroscience, spirituality, creativity, ...

Continue Reading →

Don Lattin – Psychedelic Science (MAPS) 2017 Interview



Please visit us for inspiration, ideas, information, and LOVE!
http://soulDocumentary.love

S.O.U.L. endeavors to further expand consciousness by sharing our experience from the MAPS sponsored Psychedelic Science 2017 conference, where the international scientific community came together at the Oakland Marriott City Center to explore new research into the benefits and risks of MDMA, LSD, psilocybin, ayahuasca, ketamine, ibogaine, medical cannabis, and more for such applications as: psychotherapy, neuroscience, spirituality, creativity, ...

Continue Reading →
Page 1 of 27 12345...»
UA-77446339-1